November 25th 2024
At the ESCRS meeting, Sir Harold Ridley’s legacy was put on display in a pop-up museum installation
September 7th 2024
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (CME/CNE Credit)
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (COPE Credit)
View More
(COPE) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Advancing Treatment in Neovascular Retinal Disease with Novel Therapies: Insights and Strategies from Latest Real-World and Clinical Data
View More
Rapid Reviews in Retina™: Emerging Updates from Fall 2023 – Addressing the Wealth of New Data in Treatments for nAMD and DME
View More
(CME) Stratifying the Spectrum of Care in Glaucoma Management – Advancing Treatment with a Vast Armamentarium
View More
(CME) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon
View More
(COPE) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon
View More
(CME) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment
View More
(COPE) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment
View More
(CME) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape
View More
(COPE) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape
View More
Managing Ocular Toxicities in Patients With Cancer: Understanding ADCs and the ECP’s Role in Collaborative Management Therapy on the Horizon (CME Credit)
View More
Managing Ocular Toxicities in Patients With Cancer: Understanding ADCs and the ECP’s Role in Collaborative Management Therapy on the Horizon (COPE Credit)
View More
SimulatED™: Applying Advanced Treatment for nAMD & DME - Simulating New Strategies for Clinical Management
View More
EnVision Summit
February 14-17, 2025
Register Now!
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (COPE Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)
View More
Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)
View More
Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)
View More
Tiolat Oy announces new name and expansion plans
September 15th 2008On August 20th, Tiolat Oy, manufacturer of the iCare Tonometer, underwent a makeover and changed its name to iCare Finland Oy. In a conversation with Ophthalmology Times Europe, newly-appointed CEO Ari Tiukkanen outlined the reasons behind the recent name change, and discussed how the new name fits into the company's plans for the future.
How to achieve the perfect multifocal IOL implantation
September 14th 2008Good multifocal IOL (MFIOL) candidates are highly motivated to be spectacle independent and tend to have an easy going and adaptable personality. They have healthy eyes and a low degree of astigmatism. Hyperopic presbyopes tend to make the best candidates.
Surgeon controversially shuns multifocal IOLs
September 14th 2008Monovision offers a safe and an effective option while multifocals are a high risk strategy, Dr Graham D. Barrett controversially told delegates during a session that discussed whether surgeons should introduce multifocal IOLs (MFIOLs) into their practice.
One-click diagnostics from WaveLight
September 14th 2008WaveLight today introduced the Allegro BioGraph, a combined Biometer using the OLCR (Optical Low Coherence Reflectometry) measuring principle. For use in cataract and refractive surgery, the device delivers contact-free measurement, supplying data on axial eye dimensions and the complete anterior segment in a single, one-click measurement.
Patient dissatisfaction most common cause for multifocal lens explantations
September 14th 2008Preop chair time is vital for multifocal patients to correctly evaluate motivation and manage expectations correctly, Dr Jorge Alio told delegates during a presentation on how to rescue an unhappy multifocal patient.
Topcon and Oculentis join forces
September 14th 2008Topcon and Oculentis have announced a European cooperation agreement covering sales, marketing and new product development. The deal will bring Topcon into the surgical market and give Oculentis access to Topcon's extensive sales and distribution network.
Third- vs. fourth-generation quinolones: which are best in the long-term?
September 8th 2008According to a study published in the September issue of the Journal of Cataract and Refractive Surgery, differences in the pharmacokinetic and pharmacodynamic properties of quinolone antibiotics may affect the incidence of endophthalmitis following cataract surgery.
Iris recognition makes no difference to wavefront-guided LASIK outcomes
September 8th 2008There are no statistically significant differences in outcomes when wavefront-guided LASIK is performed with or without iris recognition (IR), according to a report published in the September 2008 issue of the Journal of Cataract and Refractive Surgery.
Best mode for treating hard cataracts
September 1st 2008The "multiburst" mode of bimanual microincision phacoemulsification machines is unsuitable for treating cataracts with a nuclear density of Grade 3 and above, according to study results published in the July 2008 issue of Clinical & Experimental Ophthalmology.